Measuring allele-specific expression (ASE) is a powerful approach for identifying cisregulatory genetic variants. Here we developed a novel targeted proteomics method for quantification of allele-specific protein expression (ASPE) based on scheduled high resolution multiple reaction monitoring (sMRM-HR) with a heavy stable isotope-labeled quantitative concatamer (QconCAT) internal protein standard. This strategy was applied to the determination of the ASPE of UGT2B15 in human livers using the common UGT2B15 nonsynonymous variant rs1902023 (i.e. Y85D) as the marker to differentiate expressions from the two alleles. The QconCAT standard contains both the wild type tryptic peptide and the Y85D mutant peptide at a ratio of 1:1 to ensure accurate measurement of the ASPE of UGT2B15. The results from 18 UGT2B15 Y85D heterozygotes revealed that the ratios between wild type Y allele and mutant D allele varied from 0.60 to 1.46, indicating the presence of cis-regulatory variants. In addition, we observed no significant correlations between the ASPE and mRNA ASE of UGT2B15, suggesting the involvement of different cis-acting variants in regulating the transcription and translation processes of the gene. This novel ASPE approach provides a powerful tool for capturing cis-genetic variants involved in post-transcription processes, an important yet understudied area of research.
INTRODUCTION
Gene expression can be regulated by both cis-and trans-regulatory factors. Cisregulatory genetic variants are nearby or within a gene locus that affect the gene expression in an allele-specific manner. The most well-established cis-acting variants are located in the enhancer and promoter regions of a gene 1 . Trans-regulatory factors regulate gene expression of both alleles. They can be genetic variants, such as those of transcription factors genes, or non-genetic factors, such as drug inducers, disease states, and different developmental stages. Although still an area of debate, some recently published large-scale genomic studies suggest that cis-acting variants have greater impacts on gene expression variability than trans-acting variants 2 . Because cisregulatory factors have allele-specific effects, measuring allele-specific expression (ASE) has been widely used as a powerful approach to search for cis-acting variants. Deviation of an allelic expression ratio from one would strongly suggest the presence of cisregulatory variant(s). Allelic expression analysis takes advantage of the fact that one allele serves as the control for the other, cancelling out the effects from trans-regulatory elements and non-genetic confounding factors. Thus, relative to total gene expression, ASE is unlikely to be altered by non-genetic factors and trans-regulatory elements, and thus is more sensitive and robust for the identification of functional cis-regulatory genetic variants.
Most allele-specific expression studies are conducted at the mRNA level due to technologies for the quantitative analysis of mRNA expressions being more amenable than those for protein expression measurement. However, mRNA expressions correlate poorly with protein expressions for many genes as protein abundance is subject to posttranscriptional regulations [3] [4] [5] [6] . Thus, regulatory variants identified through an mRNA ASE assay may not be predictive of protein expression in genes with poor mRNA-protein expression correlations. Furthermore, mRNA ASE analysis is unable to detect variants that affect gene expression at the post-transcriptional level (e.g. translation efficiency and protein degradation). Therefore, studies based on mRNA ASE cannot fully capture and predict the effects of cis-acting genetic variants on gene expression at the protein level.
In the present study, we developed a novel targeted proteomics assay for precise quantification of allele-specific protein expression (ASPE) using a scheduled high resolution multiple reaction monitoring (sMRM-HR) approach with a heavy stable isotope-labeled quantitative concatamer (QconCAT) internal protein standard. The UGT2B15 gene, which encodes the important phase II metabolizing enzyme UDP glucuronosyltransferase 2B15 expressed in human livers, was targeted in this proof-ofconcept study. The mutant tryptic peptide NDLEDSLLK harboring the common UGT2B15 nonsynonymous variant rs1902023 (i.e. Y85D) and its wild type counterpart NYLEDSLLK were quantified simultaneously to determine the ASPE ratios of the gene 
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( Figure 1 ). This assay exhibited excellent precision and reproducibility, and has the potential to be widely utilized for the identification cis-regulatory genetic variants. 
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MATERIALS AND METHODS
Materials
UGT2B15 QconCAT protein standard design and generation
The unique UGT2B15 peptide NYLEDSLLK and its variant peptide NDLEDSLLK (i.e., Y85D, rs1902023) were chosen as the markers for the quantification of ASPE of UGT2B15 with a QconCAT internal standard in human livers. It is important that the internal standard includes equimolar amounts of the wild type and mutant QconCAT peptides in order to precisely quantify the ASPE of a gene. Accordingly, we designed a QconCAT protein containing both NYLEDSLLK and NDLEDSLLK peptides at a ratio of centrifugation and processed using a reported method with some minor modifications 8 .
Briefly, cells were lysed with BugBuster® protein extraction reagent (EMD Millipore) and
Benzonase® nuclease (Sigma-Aldrich). The resulted inclusion bodies were suspended in 20 mmol/L disodium phosphate, 8 mol/L urea, 0.5 mol/L NaCl, 20 mmol/L imidazole (pH 7.4). QconCAT proteins were then purified using affinity chromatography with HisTrap HP columns (GE Healthcare Bio-Sciences, Pittsburgh, PA). The purified
QconCAT proteins were desalted after three rounds of dialysis using Slide-A-Lyzer G2 dialysis cassettes (3.5K MWCO, Thermo Fisher Scientific, Waltham, MA) against 50 mmol/L ammonium bicarbonate containing 1 mmol/L dithiothreitol. The QconCAT standards were stored at -80 °C until use.
Scheduled high resolution multiple reaction monitoring (sMRM-HR) analysis of UGT2B15 ASPE in human liver microsomes
To prepare human liver microsomes, approximate 200 mg frozen liver tissues were homogenized in 0.6 mL ice-cold phosphate-buffered saline (PBS) in 1.5 mL microcentrifuge tubes using a microtube homogenizer (VWR International LLC, Chicago, USA). S9 fractions were obtained after centrifugation of the homogenates at 10,000 g for 30 min at 4 °C. The supernatants (S9 fractions) were transferred to Beckman ultracentrifuge tubes and centrifuged at 300,000 g (80,000 rpm) for 20 min. Microsomes were obtained by resuspending the pellets in PBS using a microtube homogenizer.
Protein concentrations of the microsomes were determined using a Pierce TM BCA protein assay kit (Thermo Fisher Scientific, Waltham, MA). The microsome samples were stored at -80 °C until use.
A previous reported Lys-C/Trypsin combinatorial digestion protocol was utilized for protein digestion, with some modifications 9 . An aliquot of 80 μg microsome protein was mixed with a 10-fold volume of pre-cooled acetone. The mixture was briefly vortexed and incubated at -20 °C for at least 2 hours, followed by centrifugation at 17,000 g for 15 min at 4 °C. After removing the supernatants, the precipitated proteins were washed with 200 μL ice-cold 80% ethanol, and centrifuged again at 17,000 g for 15 min at 4 °C. The supernatants were discarded, and the precipitated proteins were air-dried at room temperature before being resuspended in 92.5 μL of freshly prepared 4 mM dithiothreitol in 8 M urea solution containing 100 mM ammonium bicarbonate. Next, the heavy stable isotope-labeled QconCAT UGT2B15 internal standard (75 ng) was added. Samples were then briefly vortexed and sonicated, and incubated at 37 °C for 45 min. After samples were cooled down to room temperature, 100 μL of freshly prepared 20 mM iodoacetamide in 8 M urea/100 mM ammonium bicarbonate solution was added. The mixture was incubated at room temperature for 30 min in the dark for alkylation.
Following incubation, the urea concentration was adjusted to 6 M by adding 64.6 μL of 50 mM ammonium bicarbonate. Lysyl endopeptidase (Wako Chemicals, Richmond, VA) was then added for the first step digestion at 37 °C for 6 h (protein to lysyl endopeptidase ratio = 100:1). Samples were diluted with 50 mM ammonium bicarbonate to further decrease urea concentration to 1.6 M, and then subjected to the second step of digestion with trypsin overnight at 37 °C at a protein to trypsin ratio of 50:1. Digestion was terminated by the addition of 1 μL trifluoroacetic acid. Digested peptides were extracted and purified using Waters Oasis HLB columns according to the manufacturer's instructions. Peptides eluted from the columns were dried in a SpeedVac SPD1010 concentrator (Thermo Scientific, Hudson, NH), and reconstituted in 80 μL of 3% acetonitrile solution containing 0.1% formic acid. The peptide samples were centrifuged at 17,000 g for 10 min at 4 °C, and 40 μL of the supernatant was collected and supplemented with 1 μL of the synthetic iRT standards solution (Biognosys AG, Cambridge, MA) for LC-MS/MS analysis.
Information-dependent acquisition (IDA) was performed on three pooled human liver microsome samples using the method described in a recently published study 10 Supplemental Table 1 .
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The sMRM-HR data were analyzed using the Skyline software (version 3.7.1.11271, University of Washington, Seattle, WA) 11 
UGT2B15 mRNA allele-specific expression analysis using SNapShot
Samples heterozygous for rs1902023 were also analyzed for allele-specific expression at the mRNA level using a SNaPshot method 13 . Briefly, UGT2B15 cDNA was obtained from reverse-transcription, and a fragment of DNA and UGT2B15 cDNA surrounding rs1902023 was amplified using PCR. PCR primers are listed in Supplemental Table 2 .
After degradation of un-incorporated dNTPs and excess primers with exonuclease I and Antarctic alkaline phosphatase, PCR products were then subjected to a primer extension assay (SNaPshot kit, Life Tech, Grand Island, NY) using extension primers designed to anneal to the amplified DNA adjacent to the rs1902023 site. The resulting primer extension products were then analyzed on an ABI3730 capillary electrophoresis DNA instrument using Gene Mapper software (Life Tech, Grand Island, NY). Two independent measurements, each in duplicates, were performed.
RESULTS
Out of the 40 liver samples genotyped by Pyrosequencing, a total of 18 were found to be heterozygous for the UG2B15 variant Y85D. A heavy isotope-labeled standard was successfully generated using a QconCAT approach (Supplemental Figure 1 (Figure 4) . The mRNA ASE of UGT2B15 were quantified using a SNapShot method based on the same genetic marker Y85D (rs1902023). The mRNA ASE ratios were between 0.68 and 1.24 with a mean value of 0.89. However, no significant correlation was found between the ASPE and the mRNA ASE ratios ( Figure 5 ). 
DISCUSSION
We have developed a QconCAT-based targeted proteomics approach for the measurement of ASPE with high precision and reproducibility. Applying this approach to determining UGT2B15 ASPE in human livers, we revealed a robust allelic difference in protein expression of UGT2B15. The ASPE cannot be explained by mRNA ASE, indicating the presence of cis-acting regulatory variants affecting UGT2B15 expression at the post-transcriptional level. The results demonstrate that this novel ASPE approach has the potential to be widely utilized for the identification of cis-acting genetic variants that can be difficult to be detected by conventional mRNA and/or protein expressionbased methods.
Despite extensive research in the past several decades, a significant portion of inheritable phenotypes for many genes cannot be explained by the functional genetic variants identified so far. For example, the catalytic activity of CYP3A4, one of the most abundantly expressed phase I enzymes in human livers, is highly correlated to protein expression and markedly inheritable (66% -88%) according to both an early twin study and a more recent study using a repeated drug administration approach 14, 15 . However, all identified functional genetic variants can only explain less than 30% of the variability in CYP3A4 function. The gap between the expected and known genetic contributions to phenotypic traits is termed "missing heritability" 16 . Identifying genetic variants that accounts for "missing heritability" is paramount for the understanding of interindividual variability in various phenotypes, such as diseases susceptibility and response to drug therapy.
The most commonly used approach to identify regulatory genetic variants is to measure total mRNA expression or mRNA ASE and then search for genetic variants associated with the mRNA expression or ASE imbalance. However, numerous studies have demonstrated that the correlations between mRNA and protein expressions are very poor for many genes [3] [4] [5] [6] . Genetic variants associated with altered mRNA expression levels may not necessarily affect protein expression of the gene (i.e. false positive) 3 , which could be partially due to a stronger evolutionary constraint at protein level relative to mRNA expression 17 . Furthermore, genetic polymorphisms affecting gene expression at the protein level may not be readily detected by mRNA expression-based approaches (i.e. false negative) 4, 18, 19 . For example, several linked variants were strongly associated with protein levels of the apolipoprotein L. 2 (APOL2) gene, but the effect was unrelated to either mRNA or ribosome occupancy 4 . It is not uncommon that functional genetic variants identified from an mRNA expression study were later found to have no observable effects on protein expression and/or clinical phenotypes. The lack of correlation between mRNA and protein expressions may in part explain this discrepancy.
In recent years, with the progress of mass spectrometry-based quantitative proteomics, protein expression has been increasingly utilized as a phenotype for the study of functional regulatory genetic variants 4, 20 . In most biological processes, protein instead of mRNA is the functional molecule; thus genetic variants associated with protein expression levels are more likely to be biologically relevant. It should be noted that in addition to genetic variants, many non-genetic factors such as inducers and disease state can also affect protein expression 21 . Therefore, observation of elevated or decreased protein expression doesn't necessarily suggest the existence of functional regulatory genetic variants. Consequently, using protein expression level as the phenotype for identifying functional genetic variants can be significantly confounded by non-genetic regulatory elements, which may significantly impair the statistical power of that approach and lead to false positive or negative findings.
Both cis-and trans-acting elements contribute to interindividual variability in gene expression. Cis-acting variants affect gene expression in an allele-specific manner, resulting in an ASPE ratio deviating from one. In contrast, trans-regulatory variants and environmental factors affect gene expression of both alleles, thus the ASPE ratio remains one. Therefore, measuring ASPE could be a powerful approach for the study of to the variants associated with protein stability 22 . In principle, this type of variants cannot be identified by mRNA ASE-based studies, but will be readily detected by an ASPE assay. ASPE has been quantified in several proteomics studies, which revealed wide spread contributions of cis-regulatory factors to variability in protein expression 4, 23, 24 .
However, the data-dependent acquisition (DDA) or label-free proteomics techniques utilized in these studies exhibit intrinsic limitations in the accuracy, precision, and repeatability of protein quantification 25 . In the present study, we developed a novel sMRM-HR method using a heavy stable isotope-labeled QconCAT protein standard for the measurement of UGT2B15 ASPE in human liver. UGT2B15 was chosen as the model gene for this proof-of-concept ASPE study due to 1) playing an important role in the metabolism of some endobiotics, such as steroid hormones, and several clinically important medications; 2) its protein expression varies markedly among individuals 5 , however, genetic variants responsible for the expression variability remain largely undetermined; and 3) the nonsynonymous variant Y85D (rs1902023) is very common, with a minor allele frequency ranging from 44% to 64% in different populations, allowing 20 adequate numbers of Y85D heterozygotes to be obtained from our banked human liver samples.
Combined with the use of heavy isotope-labeled internal standards, targeted proteomics approaches, such as the sMRM-HR method used in the present study enable the most accurate and reproducible protein quantification relative to other untargeted and/or unlabeled proteomics methods. QconCAT-based targeted proteomics haves been used for the quantification of many proteins including UGT2B15 26, 27 . The QconCAT protein standard we designed differs from conventional QconCAT standard in two important aspects. First, the standard contains both the wild type surrogate peptide NYLEDSLLK and the mutant Y85D peptide NDLEDSLLK at a ratio of 1:1, which ensures that the heavy internal standard contains equimolar amounts of the two peptides. Second, both the wild type and mutant peptides are flanked by at least 15 native UGT2B15 amino acids to enable identical digestion efficiencies for both the heavy QconCAT peptides and the light peptides from human liver samples ( Figure 2 ). The digestion enzyme trypsin interacts with three to four amino acid residues around scissile bonds, and certain residues, such as negatively charged amino acids, can significantly affect the digestion efficiency of trypsin 28, 29 . Thus, digestion efficiency of the concatenated surrogate peptides in a conventional QconCAT protein can differ significantly from that of the peptides in native proteins, which imposes significant challenges on the accuracy and repeatability of QconCAT-based quantitative proteomics. Cheung et al. assessed the effect of natural amino acid flanking sequence on trypsin digestion efficiency of QconCAT proteins and concluded that including six or more amino acid flanking residues is necessary for reliable quantification 30 . In the preset study, we included at least 15 native flanking amino acids to ensure accurate measurement of any departure of ASPE ratios from one. This new approach has demonstrated excellent sensitivity and reproducibility, and revealed a significant ASPE imbalance of UGT2B15 in human livers, with the Y-to-D allele ratios from 0.61 to 1.42, indicating the presence of cis-regulatory variant(s) of the gene. In addition, no significant correlation was observed between the ASPE and mRNA ASE, suggesting the existence of post-transcriptional regulatory variants capable of regulating UGT2B15 protein expression independent of the variants causing the mRNA ASE imbalance. This observation is consistent with a previous study showing that UGT2B15 mRNA expressions did not significantly correlate to its protein levels in human livers 5 . These results highlight the utility of this novel ASPE assay in determining genetic variants involved in post-transcriptional regulation, and further emphasize the importance of studying gene expression regulation at the protein level. 
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